Belite Bio, Inc <BLTE.O>: H.C. Wainwright Raises Target Price to $214 From $200
BLTE•Related News
Antalpha to report Q2 2026 results, host conference call
ANTA•
Altimmune Q2 FY26 net loss narrows to $22.8 million; cash and investments climb to $519 million
ALT•
Veritone, ZeroEyes partner on real-time weapons detection alerts, post-event analysis
VERI•
Definium says LSD-based pill reduces anxiety in late-stage study
DFTX•
Unicycive Therapeutics Announces Second Quarter 2026 Financial Results And Provides Business Update
UNCY•